Preimplantation Genetic Testing for Aneuploidy is proven to be effective at identifying chromosomally normal (euploid) and chromosomally abnormal (aneuploid) embryos. It is an accurate, safe, and cost-effective genetics screening service that helps fertility clinics improve the implantation rate for their patients’ success rate for a healthy pregnancy.
Non-invasive prenatal testing (NIPT), also known as cell-free DNA (cfDNA) screening, is a safe, simple and reliable method of screening for common chromosome abnormalities as early as 10 weeks into pregnancy. A simple blood test is all that’s required, and results will be received within 5 days.
Access Genomics’ board-certified counsellors, work in collaboration with your fertility physician, to explain genetic risks, and the genetic screening options available.